Haas Jason
CIK: 0001883821•Chief Financial Officer
Officer
Primary company: Syros Pharmaceuticals, Inc. (SYRS)
Haas Jason is a corporate insider (Chief Financial Officer) at Syros Pharmaceuticals, Inc. (SYRS) filing SEC Form 4 transactions. 41 transactions across 2 companies, totaling $161,240 in purchases and $28,980 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Exercise | 1,000 | $51.56 | $52K | 6,138 | 6/12/2026 Filed: 6/12/2026 | Filing → | |
| Exercise | 3,000 | $51.56 | $155K | 7,138 | 6/12/2026 Filed: 6/12/2026 | Filing → | |
| Sale | 3,461 | $256.08 | $886K | 4,981 | 6/12/2026 Filed: 6/12/2026 | Filing → | |
| Sale | 3,000 | $255.01 | $765K | 8,442 | 6/12/2026 Filed: 6/12/2026 | Filing → | |
| Exercise | 1,000 | $51.56 | $52K | 11,442 | 6/12/2026 Filed: 6/12/2026 | Filing → | |
| Exercise | 3,000 | $51.56 | $155K | 10,442 | 6/12/2026 Filed: 6/12/2026 | Filing → | |
| Award | 2,938 | $237.00 | $696K | 2,938 | 6/5/2026 Filed: 6/5/2026 | Filing → | |
| Award | 836 | - | - | 7,442 | 6/5/2026 Filed: 6/5/2026 | Filing → | |
Odyssey Therapeutics, Inc. ODTX | Purchase | 1,000 | $20.00 | $20K | 62,908 | 5/8/2026 Filed: 5/8/2026 | Filing → |
| Award | 5,783 | - | - | 5,783 | 6/6/2025 Filed: 6/10/2025 | Filing → | |
| Award | 1,209 | - | - | 6,606 | 6/6/2025 Filed: 6/10/2025 | Filing → | |
| Sale | 137,803 | $0.21 | $29K | 0 | 11/18/2024 Filed: 11/20/2024 | Filing → | |
| Exercise | 18,875 | - | - | 0 | 10/31/2024 Filed: 11/4/2024 | Filing → | |
| Tax Payment | 5,624 | $2.09 | $12K | 137,803 | 10/31/2024 Filed: 11/4/2024 | Filing → | |
| Exercise | 18,875 | - | - | 143,427 | 10/31/2024 Filed: 11/4/2024 | Filing → | |
| Purchase | 45,344 | $1.68 | $76K | 124,552 | 9/12/2024 Filed: 9/12/2024 | Filing → | |
| Purchase | 19,293 | $1.58 | $30K | 79,208 | 9/11/2024 Filed: 9/12/2024 | Filing → | |
| Purchase | 35,363 | $1.55 | $55K | 59,915 | 9/10/2024 Filed: 9/12/2024 | Filing → | |
| Award | 5,444 | - | - | 5,444 | 6/14/2024 Filed: 6/18/2024 | Filing → | |
| Award | 1,252 | - | - | 5,397 | 6/14/2024 Filed: 6/18/2024 | Filing → |
Type
Exercise
Shares
1,000
Price
$51.56
Value
$52K
Type
Exercise
Shares
3,000
Price
$51.56
Value
$155K
Type
Sale
Shares
3,461
Price
$256.08
Value
$886K
Type
Sale
Shares
3,000
Price
$255.01
Value
$765K
Type
Exercise
Shares
1,000
Price
$51.56
Value
$52K
Type
Exercise
Shares
3,000
Price
$51.56
Value
$155K
Type
Award
Shares
2,938
Price
$237.00
Value
$696K
Type
Award
Shares
836
Price
-
Value
-
Odyssey Therapeutics, Inc.
ODTX
Type
Purchase
Shares
1,000
Price
$20.00
Value
$20K
Type
Award
Shares
5,783
Price
-
Value
-
Type
Award
Shares
1,209
Price
-
Value
-
Type
Sale
Shares
137,803
Price
$0.21
Value
$29K
Type
Exercise
Shares
18,875
Price
-
Value
-
Type
Tax Payment
Shares
5,624
Price
$2.09
Value
$12K
Type
Exercise
Shares
18,875
Price
-
Value
-
Type
Purchase
Shares
45,344
Price
$1.68
Value
$76K
Type
Purchase
Shares
19,293
Price
$1.58
Value
$30K
Type
Purchase
Shares
35,363
Price
$1.55
Value
$55K
Type
Award
Shares
5,444
Price
-
Value
-
Type
Award
Shares
1,252
Price
-
Value
-
AI Agent
Try asking...